Wishes for Elliott is ranked #11 of 24 disease & disorders organizations in Washington, DC, with an America's Best Score of 75 out of 100, based on its 2024 Form 990.
Wishes for Elliott is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G54). Contributions are tax-deductible.
1234 Crittenden St Nw, Washington, DC 20011-4431
Among the 42 scored disease & disorders organizations in Washington, Wishes for Elliott holds 26 months of operating reserves (peer median 11.4 months), runs a typical yearly surplus of 88.7% (peers: deficit of 0.9%), and has grown spending 38.2% a year (peers: grown spending 8.2% a year).
In fiscal year 2024 it reported $902,175 in revenue and $496,581 in expenses, with contributions making up 94.6% of revenue.
We work collaboratively to accelerate the pace of science on scn8a and related disorders in order to bring hope and improved outcomes for all those living with rare epilepsies and their families.
Largest programs · fiscal year 2023
Research ? Since 2015, the international scn8a alliance has helped build the core of researchers committed to finding answers by funding early career researchers. With 90% of our grantees still focused on scn8a and related research after their grants are completed, these early career researchers are opening their labs and conducting novel research on a range of emerging and entrenched issues relat… Read more
Research ? Since 2015, the international scn8a alliance has helped build the core of researchers committed to finding answers by funding early career researchers. With 90% of our grantees still focused on scn8a and related research after their grants are completed, these early career researchers are opening their labs and conducting novel research on a range of emerging and entrenched issues related to scn8a and rare epilepsies. Please see schedule o for additional information on research accomplishments. We also host scientific meetings to align the community on critical research efforts and to help ensure coordination and collaboration across the globe. These meetings are catalysts for new partnerships and advancing scientific progress in both scn8a and dees.
$251,552 spent · 100.0% of program spending
Education: We work to improve the understanding of scn8a by ensuring that stakeholders foster relationships break down barriers and collaborate to find treatments and improve the quality of life for all. Education is a two?way street. We learn from families and we provide opportunities for families to engage with researchers pharma clinicians regulators and beyond. We pull down silos that stall pr… Read more
Education: We work to improve the understanding of scn8a by ensuring that stakeholders foster relationships break down barriers and collaborate to find treatments and improve the quality of life for all. Education is a two?way street. We learn from families and we provide opportunities for families to engage with researchers pharma clinicians regulators and beyond. We pull down silos that stall progress and ensure all are working with the utmost speed to reach our goal a cure for our children. For scn8a, we host meetups weekly (with 4 language groups) to discuss what we are learning from our registry and hear from families. Across the development and epileptic encephalopathies, via our dee?p connections project, we have hosted more than 70 interactive webinars since 2020 to bring critical information and resources to dee caregivers.
Advocacy ? Our efforts, spanning both the broad range of developmental and epileptic encephalopathies (dees) and scn8a, include diverse advocacy efforts to both legislative and administrative policymakers. Our legislative advocacy includes multiple efforts addressing pending legislative actions and appropriations that affect supported research and support for families (i.e., proposed Medicaid chan… Read more
Advocacy ? Our efforts, spanning both the broad range of developmental and epileptic encephalopathies (dees) and scn8a, include diverse advocacy efforts to both legislative and administrative policymakers. Our legislative advocacy includes multiple efforts addressing pending legislative actions and appropriations that affect supported research and support for families (i.e., proposed Medicaid changes) as well as advocating for additional federal funding for translational epilepsy research. To ensure our community is heard, we have also provided multiple comments to federal agencies, including the fda, nih, and cdc, often but not exclusively in response to published rfis. A significant effort included a submission of data and family stories for the fda to provide required context about scn8a patient perspectives, priorities, and lived experiences. Another was substantive feedback on fda draft guidance on clinical outcome assessments. Both submissions were well received.
Where each dollar went · fiscal year 2023
Of every dollar it spent, 81¢ went to programs, 13¢ to management and 6¢ to fundraising.
Programs $251,552
Management $40,639
Fundraising $18,516
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
81%
Meets
Compared with Washington peers
Measure
This organization
Peer median
Operating reserves
26.0 mo
11.4 mo
Typical margin
+88.7%
−0.9%
Spending growth
+38.2% / yr
+8.2% / yr
Debt load
0.9%
23.4%
Peers: the 42 Washington disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$902,175Fiscal year 2024
Expenses$496,581Fiscal year 2024
Total assets$1,086,442Fiscal year 2024
Total liabilities$9,549Fiscal year 2024
Fiscal year ending December2024
Revenue$902,175
Expenses$496,581
Net income$405,594
Net assets$1,076,893
Notable sources of revenue
Percent of total revenue
Contributions
$853,884
94.6%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$48,291
5.4%
Assets / debt
Total assets
$1,086,442
Total liabilities
$9,549
Net assets
$1,076,893
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$586,220
Expenses$310,707
Net income$275,513
Net assets$671,299
Notable sources of revenue
Percent of total revenue
Contributions
$585,540
99.9%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$680
0.1%
Assets / debt
Total assets
$689,190
Total liabilities
$17,891
Net assets
$671,299
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$629,384
Expenses$260,064
Net income$369,320
Net assets$451,648
Notable sources of revenue
Percent of total revenue
Contributions
$628,810
99.9%
Program services
$0
0.0%
Investment income
$8
0.0%
Other (net)
$566
0.1%
Assets / debt
Total assets
$453,877
Total liabilities
$2,229
Net assets
$451,648
Compensation
Officers and key employees
$150,000
Share of expenses
57.7%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?